×

Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study: Om Mitta S et al.

 
Autoren:

Shivam Om Mittal    1,2,3,*
Duarte Machado   
1,4
Diana Richardson    1
Divyanshu Dubey 
 3
and Bahman Jabbari    1

 

Autoren-Details:
1   Department of Neurology, Yale University School of Medicine, New Haven, CT 06510, USA;
duarte.machado@hhchealth.org (D.M.); diana.richardson@va.gov (D.R.); bahman.jabbari@yale.edu (B.J.)

2   Department of Neurology, Columbia Asia Hospitals, Sarjapur Rd, Bangalore 560102, India
3   Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA; dubey.divyanshu@mayo.edu
4   Department of Neurology, Hartford Healthcare Ayer Neuroscience Institute, Hartford, CT 06066, USA
 Correspondence: neurology.mittal@gmail.com; Tel.: +1-(91)-983-487-9072